This manuscript briefly reviews the extensive research as well as new developments on
chitosan based nanomaterials for various applications. Chitosan is a biocompatible and …

Insulin is essential for type 1 and advanced type 2 diabetics to maintain blood glucose levels
and prolong lives. The traditional administration requires frequent subcutaneous insulin …

The development of oral dosage forms that allows absorption of therapeutic peptides to the
systemic circulation is one of the greatest challenges for the pharmaceutical industry …

The ability of nanoparticles to manipulate the molecules and their structures has
revolutionized the conventional drug delivery system. The chitosan nanoparticles, because …

Diabetes mellitus is a lifelong metabolic disease that requires frequent subcutaneous
injections of insulin. However, this method of administration can be associated with patient …

Nanoparticles have demonstrated significant advancements in potential oral delivery of
insulin. In this publication, we review the current status of polymeric, inorganic and solid-lipid …

Several polymers of both natural and synthetic origin have been used for a variety of
biomedical applications including pharmaceutical preparations, drug targeting, imaging …

Chitosan (CS), a cationic polysaccharide, is widely regarded as a safe and efficient intestinal
absorption enhancer of therapeutic macromolecules, owing to its inherent mucoadhesive …

Chitosan is the most suitable encapsulation polymer because of its natural abundance,
biodegradability, and surface functional groups in the form of free NH2 groups. The …

Diabetes mellitus, an incurable metabolic disease, is characterized by changes in the
homeostasis of blood sugar levels, being the subcutaneous injection of insulin the first line …